InterventionsHuman trial

STEP UP T2D: Participants Achieving BMI, WHtR, and Cardiometabolic Treatment Targets

ADA Scientific Sessions 2026 Abstract

The paper

Carel Le Roux, Sambit Das, Nina Majlund Harder-Lauridsen,

Ildiko Lingvay, Megha Poddar, Niklas Kahr Rasmussen,

Dublin

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 2829-LB

doi.org/10.2337/db26-2829-lb

Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026